BURRILL & COMPANY
Burrill & Company is a venture capital and private equity firm that invests in life sciences, biotechnology, and healthcare companies.
BURRILL & COMPANY
Social Links:
Industry:
Biotechnology Finance Venture Capital
Founded:
1994-01-01
Status:
Closed
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS GoDaddy
Current Advisors List
David Lawrence Senior Advisor @ Burrill & Company Advisor
Current Employees Featured
Ann F. Hanham
Ann F. Hanham Managing Director @ Burrill & Company Managing Director
Janos Redei
Janos Redei Entrepreneur @ Burrill & Company Entrepreneur
Sven Rohmann
Sven Rohmann Managing Director @ Burrill & Company Managing Director
Irena Melnikova
Irena Melnikova Managing Director @ Burrill & Company Managing Director
Konstantin G. Skryabin
Konstantin G. Skryabin Venture Partner @ Burrill & Company Venture Partner
Simon Waddington
Simon Waddington Entrepreneur @ Burrill & Company Entrepreneur
Derek Wong
Derek Wong Associate @ Burrill & Company Associate
Garrett Vygantas
Garrett Vygantas Entrepreneur-In-Residence @ Burrill & Company Entrepreneur-In-Residence
Stephen M. Sammut
Stephen M. Sammut Venture Partner @ Burrill & Company Venture Partner
Marcus Albernaz
Marcus Albernaz Associate @ Burrill & Company Associate
Founder
G. Steven Burrill
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2015-02-19 | Neos Therapeutics | Burrill & Company investment in Venture Round - Neos Therapeutics | 20.62 M USD |
2014-04-17 | Nora Therapeutics | Burrill & Company investment in Series B - Nora Therapeutics | 18 M USD |
2014-03-04 | Neos Therapeutics | Burrill & Company investment in Series C - Neos Therapeutics | 15.5 M USD |
2013-10-22 | BetterDoctor | Burrill & Company investment in Seed Round - BetterDoctor | 2.6 M USD |
2013-05-29 | NewBridge Pharmaceuticals | Burrill & Company investment in Series C - NewBridge Pharmaceuticals | 48 M USD |
2013-04-01 | Catalyst Biosciences | Burrill & Company investment in Post-IPO Equity - Catalyst Biosciences | 5.07 M USD |
2013-02-14 | Strand Life Sciences | Burrill & Company investment in Series B - Strand Life Sciences | N/A |
2013-02-14 | Odyssey Thera | Burrill & Company investment in Venture Round - Odyssey Thera | 2.8 M USD |
2012-11-20 | MabVax Therapeutics | Burrill & Company investment in Series B - MabVax Therapeutics | 5.25 M USD |
2012-10-01 | Cobalt Technologies | Burrill & Company investment in Venture Round - Cobalt Technologies | 4.98 M USD |